Effect of Everolimus Treatment on Chromogranin A, Neuron-Specific Enolase, Gastrin, and Glucagon Levels in Patients With Advanced Pancreatic Neuroendocrine Tumors (pNET): Phase III RADIANT-3 Study Results.

Journal of Clinical Oncology - United States
doi 10.1200/jco.2011.29.15_suppl.10624
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)


Related search